Sexual Health

Why young HIV+ women won’t get powerful ARV soon

1 Mins read
Reading Time: < 1 minute
ARV drugs

WAR on HIV-Aids ARV drugs 
Image: FILE

 

Young HIV-positive women will wait longer to access the powerful DTG antiviral drug.

DTG (Dolutegravir) is the preferred first-line ARV in Kenya, but not recommended for women aged 15-49 because it can deform the spines of unborn babies. Read More

Related posts
Sexual Health

Revealed: The nation where you could be most likely to catch an STI...so who comes out on top?

1 Mins read
Reading Time: < 1 minute They are the third most commonly used form of contraception in the UK, behind the Pill and the hormonal implant, official data…
Sexual Health

Gonorrhoea could become 'untreatable' as cases of the STI reach record level

1 Mins read
Reading Time: < 1 minute An increasing number of people catching the sexually transmitted infection are finding it does not respond to antibiotics.  Read More
Sexual Health

The impact of HIV/AIDS and STIs on fertility: What Indian couples need to know

1 Mins read
Reading Time: < 1 minute Sexually transmitted infections (STIs) and reproductive tract infections (RTIs) are major global health issues, impacting quality of life, causing infertility, cancers, and…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.